FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291016391> ?p ?o ?g. }

• W4291016391 endingPage "8875" @default.
• W4291016391 startingPage "8875" @default.
• W4291016391 abstract "The development of novel target therapies based on the use of RNA interference (RNAi) and antisense oligonucleotides (ASOs) is growing in an exponential way, challenging the chance for the treatment of the genetic diseases and cancer by hitting selectively targeted RNA in a sequence-dependent manner. Multiple opportunities are taking shape, able to remove defective protein by silencing RNA (e.g., Inclisiran targets mRNA of protein PCSK9, permitting a longer half-life of LDL receptors in heterozygous familial hypercholesteremia), by arresting mRNA translation (i.e., Fomivirsen that binds to UL123-RNA and blocks the translation into IE2 protein in CMV-retinitis), or by reactivating modified functional protein (e.g., Eteplirsen able to restore a functional shorter dystrophin by skipping the exon 51 in Duchenne muscular dystrophy) or a not very functional protein. In this last case, the use of ASOs permits modifying the expression of specific proteins by modulating splicing of specific pre-RNAs (e.g., Nusinersen acts on the splicing of exon 7 in SMN2 mRNA normally not expressed; it is used for spinal muscular atrophy) or by downregulation of transcript levels (e.g., Inotersen acts on the transthryretin mRNA to reduce its expression; it is prescribed for the treatment of hereditary transthyretin amyloidosis) in order to restore the biochemical/physiological condition and ameliorate quality of life. In the era of precision medicine, recently, an experimental splice-modulating antisense oligonucleotide, Milasen, was designed and used to treat an 8-year-old girl affected by a rare, fatal, progressive form of neurodegenerative disease leading to death during adolescence. In this review, we summarize the main transcriptional therapeutic drugs approved to date for the treatment of genetic diseases by principal regulatory government agencies and recent clinical trials aimed at the treatment of cancer. Their mechanism of action, chemical structure, administration, and biomedical performance are predominantly discussed." @default.
• W4291016391 created "2022-08-13" @default.
• W4291016391 creator A5034663405 @default.
• W4291016391 creator A5049689236 @default.
• W4291016391 creator A5068781793 @default.
• W4291016391 creator A5087219099 @default.
• W4291016391 date "2022-08-09" @default.
• W4291016391 modified "2023-09-25" @default.
• W4291016391 title "Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets" @default.
• W4291016391 cites W1484817497 @default.
• W4291016391 cites W1503667331 @default.
• W4291016391 cites W1510644906 @default.
• W4291016391 cites W1611419331 @default.
• W4291016391 cites W1647075334 @default.
• W4291016391 cites W1744376040 @default.
• W4291016391 cites W1780086376 @default.
• W4291016391 cites W1936171120 @default.
• W4291016391 cites W1968786809 @default.
• W4291016391 cites W1968949098 @default.
• W4291016391 cites W1973268287 @default.
• W4291016391 cites W1977989310 @default.
• W4291016391 cites W1978274374 @default.
• W4291016391 cites W1988142400 @default.
• W4291016391 cites W1989006164 @default.
• W4291016391 cites W1990548509 @default.
• W4291016391 cites W1992226313 @default.
• W4291016391 cites W1994027887 @default.
• W4291016391 cites W1997017456 @default.
• W4291016391 cites W2002962154 @default.
• W4291016391 cites W2012893162 @default.
• W4291016391 cites W2014245338 @default.
• W4291016391 cites W2017788990 @default.
• W4291016391 cites W2019292153 @default.
• W4291016391 cites W2022449818 @default.
• W4291016391 cites W2030093162 @default.
• W4291016391 cites W2033618457 @default.
• W4291016391 cites W2034921833 @default.
• W4291016391 cites W2056360850 @default.
• W4291016391 cites W2057319400 @default.
• W4291016391 cites W2064997783 @default.
• W4291016391 cites W2065611025 @default.
• W4291016391 cites W2065744098 @default.
• W4291016391 cites W2066246322 @default.
• W4291016391 cites W2074977276 @default.
• W4291016391 cites W2077513057 @default.
• W4291016391 cites W2079266971 @default.
• W4291016391 cites W2084565016 @default.
• W4291016391 cites W2085726823 @default.
• W4291016391 cites W2086038769 @default.
• W4291016391 cites W2094269170 @default.
• W4291016391 cites W2095295884 @default.
• W4291016391 cites W2106625506 @default.
• W4291016391 cites W2114765209 @default.
• W4291016391 cites W2114775015 @default.
• W4291016391 cites W2114788766 @default.
• W4291016391 cites W2117857186 @default.
• W4291016391 cites W2127497651 @default.
• W4291016391 cites W2129825215 @default.
• W4291016391 cites W2133313719 @default.
• W4291016391 cites W2134773678 @default.
• W4291016391 cites W2135409663 @default.
• W4291016391 cites W2136447541 @default.
• W4291016391 cites W2139269097 @default.
• W4291016391 cites W2143045300 @default.
• W4291016391 cites W2145665475 @default.
• W4291016391 cites W2152643817 @default.
• W4291016391 cites W2154164444 @default.
• W4291016391 cites W2155384808 @default.
• W4291016391 cites W2157220550 @default.
• W4291016391 cites W2160966221 @default.
• W4291016391 cites W2165413935 @default.
• W4291016391 cites W2169140729 @default.
• W4291016391 cites W2174791834 @default.
• W4291016391 cites W2200765141 @default.
• W4291016391 cites W2266139607 @default.
• W4291016391 cites W2315899065 @default.
• W4291016391 cites W2323840860 @default.
• W4291016391 cites W2335885701 @default.
• W4291016391 cites W2336291942 @default.
• W4291016391 cites W2336804014 @default.
• W4291016391 cites W2407531000 @default.
• W4291016391 cites W2407574353 @default.
• W4291016391 cites W2493218919 @default.
• W4291016391 cites W2510304580 @default.
• W4291016391 cites W2513798760 @default.
• W4291016391 cites W2533952864 @default.
• W4291016391 cites W2546490688 @default.
• W4291016391 cites W2554447993 @default.
• W4291016391 cites W2555618127 @default.
• W4291016391 cites W2580949752 @default.
• W4291016391 cites W2591728558 @default.
• W4291016391 cites W2591778805 @default.
• W4291016391 cites W2593722738 @default.
• W4291016391 cites W2593956993 @default.
• W4291016391 cites W2600519390 @default.
• W4291016391 cites W2610126165 @default.
• W4291016391 cites W2624920353 @default.
• W4291016391 cites W2625935660 @default.

• next